Hemorrhagic Fever, Ebola - 25 Studies Found Estado Estudiar Completed Nombre del estudio: Efficacy of Favipiravir Against Ebola (JIKI) Condición: Ebola Virus Disease Fecha: 2014-12-16 Intervenciones: Drug: Favipiravir Group A1: Day-0 (inclusion), h0: 2400 mg Withdrawn Nombre del estudio: Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola) Condición: Ebola Virus Disease Fecha: 2014-11-21 Intervenciones: Drug: Best Supportive Care Deh Active, not recruiting Nombre del estudio: Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012) Condición: Prevention of Ebola Infection Fecha: 2015-07-17 Intervenciones: Biological: V920 Consistency Lot A Recruiting Nombre del estudio: Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up Condición: Ebola Virus Disease Fecha: 2015-04-30 Recruiting Nombre del estudio: PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response Condición: Ebola Virus Disease Fecha: 2017-03-30 <<< Previous